JP2021517134A5 - - Google Patents

Info

Publication number
JP2021517134A5
JP2021517134A5 JP2020547036A JP2020547036A JP2021517134A5 JP 2021517134 A5 JP2021517134 A5 JP 2021517134A5 JP 2020547036 A JP2020547036 A JP 2020547036A JP 2020547036 A JP2020547036 A JP 2020547036A JP 2021517134 A5 JP2021517134 A5 JP 2021517134A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
comprises administering
method comprises
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020547036A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021517134A (ja
JP7396991B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/055576 external-priority patent/WO2019170750A1/en
Publication of JP2021517134A publication Critical patent/JP2021517134A/ja
Publication of JP2021517134A5 publication Critical patent/JP2021517134A5/ja
Application granted granted Critical
Publication of JP7396991B2 publication Critical patent/JP7396991B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020547036A 2018-03-07 2019-03-06 癌、潰瘍性大腸炎、及び関連する炎症性疾患の処置に有用な方法、並びにイソインドリン-1,3-ジオン及びイソインドールプロドラッグの組成物 Active JP7396991B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862639650P 2018-03-07 2018-03-07
US62/639,650 2018-03-07
PCT/EP2019/055576 WO2019170750A1 (en) 2018-03-07 2019-03-06 Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating cancer, ulcerative colitis and related inflammatory diseases

Publications (3)

Publication Number Publication Date
JP2021517134A JP2021517134A (ja) 2021-07-15
JP2021517134A5 true JP2021517134A5 (enExample) 2022-03-15
JP7396991B2 JP7396991B2 (ja) 2023-12-12

Family

ID=65894963

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020547036A Active JP7396991B2 (ja) 2018-03-07 2019-03-06 癌、潰瘍性大腸炎、及び関連する炎症性疾患の処置に有用な方法、並びにイソインドリン-1,3-ジオン及びイソインドールプロドラッグの組成物

Country Status (11)

Country Link
US (1) US11639332B2 (enExample)
EP (1) EP3762365B1 (enExample)
JP (1) JP7396991B2 (enExample)
AR (1) AR114666A1 (enExample)
AU (1) AU2019229583B2 (enExample)
CA (1) CA3093196A1 (enExample)
ES (1) ES2987705T3 (enExample)
MA (1) MA52266A (enExample)
MX (1) MX2020009288A (enExample)
TW (1) TW202000646A (enExample)
WO (1) WO2019170750A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118370746A (zh) * 2024-04-25 2024-07-23 江苏省中医院 马尿酸在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2472965A (en) * 1949-06-14 Metallized tetrakisazo dyes
US3951943A (en) 1974-03-18 1976-04-20 Chemetron Corporation Coupling process in the preparation of disazo diimides
EP0856562A1 (en) * 1997-01-31 1998-08-05 Hodogaya Chemical Co Ltd Recording liquid and novel metal complex compound contained therein
US7182953B2 (en) 1999-12-15 2007-02-27 Celgene Corporation Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
WO2002001667A1 (en) * 2000-06-29 2002-01-03 Nippon Kayaku Kabushiki Kaisha Dye-sensitized photoelectric transducer
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
CA2691716A1 (en) 2007-06-29 2009-01-08 John Francis Gilmer Targeting diazo prodrugs for the treatment of gastrointestinal diseases
EP2276483B1 (en) 2008-03-27 2014-05-07 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
WO2012083153A1 (en) * 2010-12-16 2012-06-21 Nektar Therapeutics Oligomer-containing apremilast moiety compounds
EP2663549B1 (en) 2011-01-10 2018-03-14 Celgene Corporation Phenethylsulfone isoindoline derivatives as inhibitors of pde 4 and/or cytokines

Similar Documents

Publication Publication Date Title
RU2448096C2 (ru) Диарилгидантоины
JP2008535903A5 (enExample)
JP2009507909A5 (enExample)
MX2008010187A (es) Tratamiento de distrofia muscular de duchenne.
JP2019094345A5 (enExample)
JP2009526830A5 (enExample)
RU2006133898A (ru) Производные бензимидазола и его применение
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2020527588A5 (enExample)
RU2006110186A (ru) Алкокси замещенные имидазохинолины
JP2006524222A5 (enExample)
JP2009538897A5 (enExample)
JP2008512348A5 (enExample)
JP2009535307A5 (enExample)
JP2008513498A5 (enExample)
JP2008526999A5 (enExample)
JP2011513475A5 (enExample)
RU2007119562A (ru) Тетрациклические производные индолов в качестве противовирусных агентов
JP2012507566A5 (enExample)
JP2013532652A5 (enExample)
RU2009144538A (ru) Новые циклические пептидные соединения
JP2010536842A5 (enExample)
WO2008147557A3 (en) Heteroaryl substituted thiazoles and their use as antiviral agents
RU2017118165A (ru) Ингибиторы энхансера гомолога 2 zestes
RU2013146659A (ru) Способы лечения рака